Spontaneous loss of chronic HBV infection markers in treatment-naïve children: a systematic review and pooled meta-analyses

Expert Rev Anti Infect Ther. 2021 May;19(5):649-660. doi: 10.1080/14787210.2021.1845652. Epub 2020 Nov 23.

Abstract

Objectives: Chronicity could be a serious threat to hepatitis B virus (HBV)-infected children. The necessity of antiviral treatment to HBV-infected children has caused much controversy. The authors aimed to conduct a systematic review and meta-analysis of synthesized evidence regarding the spontaneous loss of chronic HBV infection markers in treatment-naïve children for exploring their long-term management.Methods: Observational cohort studies and non-treatment arms of randomized controlled trials were searched that reported the spontaneous loss of chronic HBV infection markers in untreated children (characterized by the presence of HBsAg ≥6-month), via the rates of hepatitis B surface antigen (HBsAg) loss, hepatitis B e antigen (HBeAg) seroconversion, and HBV DNA suppression with random-effects model.Results: Of 7,427 studies screened, 20 were included in meta-analysis. With cumulative 23,153 person-years of follow-up, the pooled annual incidences of HBsAg and HBeAg loss, HBV DNA suppression were 1, 6, 7%, respectively. Rates within HBeAg loss and HBV DNA suppression did differ by the transmission modes and ALT levels, not in HBsAg.Conclusion: Spontaneous HBsAg loss (function cure) occurs infrequently in treatment-naïve children with chronic HBV infection. Design of practically applicable programs aiming at therapeutics of children may be necessary to support the goal of eliminating HBV infection worldwide.

Keywords: ALT level; Children; antiviral therapy natural history; chronic HBV infection markers; regional endemicity; transmission mode.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Biomarkers / blood
  • Child
  • DNA, Viral / blood
  • Hepatitis B Surface Antigens / blood*
  • Hepatitis B e Antigens / blood*
  • Hepatitis B virus / isolation & purification*
  • Hepatitis B, Chronic / blood
  • Hepatitis B, Chronic / virology*
  • Humans
  • Randomized Controlled Trials as Topic

Substances

  • Biomarkers
  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens